Hayato Akimoto

Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS

Hayato Akimoto, Akio Negishi, Shinji Oshima et al. · American Journal of Alzheimer s Disease & Other Dementias® · 2020 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Changes in brain metabolites related to stress resilience: Metabolomic analysis of the hippocampus in a rat model of depression

Hayato Akimoto, Shinji Oshima, Tomoaki Sugiyama et al. · Behavioural Brain Research · 2018 · 40 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: A retrospective cohort study

Hayato Akimoto, Kotoe Tezuka, Yayoi Nishida et al. · Pharmacology Research & Perspectives · 2019 · 29 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of <scp>MAE</scp> s

Hayato Akimoto, Akio Negishi, Shinji Oshima et al. · Pharmacology Research & Perspectives · 2018 · 22 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies

Takuya Nagashima, T. Hayakawa, Hayato Akimoto et al. · Clinical Pharmacology & Therapeutics · 2022 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16